Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 12th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Mycoses spring in every nook and cranny. It is not only a recent phenomenon that patients get a fungal infection with their haircut, but since the easing […]
With its newly developed software platform “EUROLabPolaris” EUROIMMUN meets the demands in the increasingly globalised field of laboratory diagnostics by enabling large laboratory groups to work together on digitally-supported immunofluorescence diagnostics across several sites. In an interview Timo Schütze, the product manager responsible for the software, and Moritz Pavlik, the product manager responsible for IT
With the Corporate COVID-19 Antibody Testing Program, EUROIMMUN gives companies the possibility to offer to their staff what EUROIMMUN has already offered to their own employees: an easy, well-organised option to check their Anti-SARS-CoV-2 antibody titers for free following infection or two vaccinations. Considering the alarmingly high number of COVID-19 cases in Germany and other
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 11th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Fungal cultures and their aesthetically pleasing structures will always hold a special place in my heart, but even I must admit that the introduction of PCR into
Emerging infectious diseases is a term for new infectious diseases in humans that have either newly appeared in a population or have already existed but are rapidly increasing in incidence or geographic range. The term also covers diseases that are caused by novel pathogens. These have developed from bacteria or viruses that were previously harmless
